These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Computational simulations on the binding and reactivity of a nitrile inhibitor of the SARS-CoV-2 main protease. Ramos-Guzmán CA; Ruiz-Pernía JJ; Tuñón I Chem Commun (Camb); 2021 Sep; 57(72):9096-9099. PubMed ID: 34498651 [TBL] [Abstract][Full Text] [Related]
3. In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease. Sur VP; Sen MK; Komrskova K Molecules; 2021 Oct; 26(20):. PubMed ID: 34684780 [TBL] [Abstract][Full Text] [Related]
4. Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors. Huff S; Kummetha IR; Tiwari SK; Huante MB; Clark AE; Wang S; Bray W; Smith D; Carlin AF; Endsley M; Rana TM J Med Chem; 2022 Feb; 65(4):2866-2879. PubMed ID: 34570513 [TBL] [Abstract][Full Text] [Related]
5. Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library. Lee JY; Kuo CJ; Shin JS; Jung E; Liang PH; Jung YS Bioorg Med Chem Lett; 2021 Jun; 42():128067. PubMed ID: 33957246 [TBL] [Abstract][Full Text] [Related]
6. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease. Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058 [TBL] [Abstract][Full Text] [Related]
7. Phenylbenzopyrone of Flavonoids as a Potential Scaffold to Prevent SARSCoV-2 Replication by Inhibiting its M Potshangbam AM; Nongdam P; Kumar AK; Rathore RS Curr Pharm Biotechnol; 2021; 22(15):2054-2070. PubMed ID: 33504301 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 M Rut W; Groborz K; Zhang L; Sun X; Zmudzinski M; Pawlik B; Wang X; Jochmans D; Neyts J; Młynarski W; Hilgenfeld R; Drag M Nat Chem Biol; 2021 Feb; 17(2):222-228. PubMed ID: 33093684 [TBL] [Abstract][Full Text] [Related]
9. Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188. Lockbaum GJ; Reyes AC; Lee JM; Tilvawala R; Nalivaika EA; Ali A; Kurt Yilmaz N; Thompson PR; Schiffer CA Viruses; 2021 Jan; 13(2):. PubMed ID: 33503819 [TBL] [Abstract][Full Text] [Related]
10. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates. Kavitha K; Sivakumar S; Ramesh B Biophys Chem; 2020 Dec; 267():106478. PubMed ID: 33022567 [TBL] [Abstract][Full Text] [Related]
11. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M Chamakuri S; Lu S; Ucisik MN; Bohren KM; Chen YC; Du HC; Faver JC; Jimmidi R; Li F; Li JY; Nyshadham P; Palmer SS; Pollet J; Qin X; Ronca SE; Sankaran B; Sharma KL; Tan Z; Versteeg L; Yu Z; Matzuk MM; Palzkill T; Young DW Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34426525 [TBL] [Abstract][Full Text] [Related]
13. Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors. Ullrich S; Sasi VM; Mahawaththa MC; Ekanayake KB; Morewood R; George J; Shuttleworth L; Zhang X; Whitefield C; Otting G; Jackson C; Nitsche C Bioorg Med Chem Lett; 2021 Oct; 50():128333. PubMed ID: 34418570 [TBL] [Abstract][Full Text] [Related]
14. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease. Awoonor-Williams E; Abu-Saleh AAA Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090 [TBL] [Abstract][Full Text] [Related]
15. A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet? Macip G; Garcia-Segura P; Mestres-Truyol J; Saldivar-Espinoza B; Pujadas G; Garcia-Vallvé S Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008685 [TBL] [Abstract][Full Text] [Related]
16. Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors. Breidenbach J; Lemke C; Pillaiyar T; Schäkel L; Al Hamwi G; Diett M; Gedschold R; Geiger N; Lopez V; Mirza S; Namasivayam V; Schiedel AC; Sylvester K; Thimm D; Vielmuth C; Phuong Vu L; Zyulina M; Bodem J; Gütschow M; Müller CE Angew Chem Int Ed Engl; 2021 Apr; 60(18):10423-10429. PubMed ID: 33655614 [TBL] [Abstract][Full Text] [Related]
17. Screening of M Altomare A; Baron G; Cambiaghi G; Ferrario G; Zoanni B; Della Vedova L; Fumagalli GM; D'Alessandro S; Parapini S; Vittorio S; Vistoli G; Riso P; Carini M; Delbue S; Aldini G Molecules; 2024 Jun; 29(11):. PubMed ID: 38893578 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for the inhibition of the HCoV-NL63 main protease M Xu J; Zhu Q; Li W; Yin X; Li J Biochem Biophys Res Commun; 2024 Sep; 724():150231. PubMed ID: 38852502 [TBL] [Abstract][Full Text] [Related]
19. Estimating the binding energetics of reversible covalent inhibitors of the SARS-CoV-2 main protease: an Awoonor-Williams E Phys Chem Chem Phys; 2022 Oct; 24(38):23391-23401. PubMed ID: 36128834 [TBL] [Abstract][Full Text] [Related]
20. Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease. Gogoi N; Chowdhury P; Goswami AK; Das A; Chetia D; Gogoi B Mol Divers; 2021 Aug; 25(3):1745-1759. PubMed ID: 33236176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]